A Cure For Novo Nordisk
Novo Nordisk(US:NVO) Seeking Alphaยท2025-08-13 17:34Novo Nordisk ( NVO ) is a struggling stock in an unloved sector. But the cure for that is lower prices. NVO has now declined 70% to $45, which is around the level where the significant 2022-2024 rally started. This article looks at why this area shouldMy approach is long-term and I focus on investing in macro ideas through low risk ETFs and CEFs. I have traded stocks and currencies for nearly ten years and currently run a family fund with my partner and fellow SA contributor Andrew McElroy. I also invest in ...